International Efforts in Nanoinformatics Research Applied to Nanomedicine

BACKGROUND Nanomedicine and nanoinformatics are novel disciplines facing substantial challenges. Since nanomedicine involves complex and massive data analysis and management, a new discipline named nanoinformatics is now emerging to provide the vision and the informatics methods and tools needed for such purposes. Methods from biomedi-cal informatics may prove applicable with some adaptation despite nanomedicine involving different biophysical and biochemical characteristics of nanomaterials and corresponding differences in information complexity. OBJECTIVES We analyze recent initiatives and opportunities for research in nanomedicine and nanoinformatics as well as the previous experience of the authors, particularly in the context of a European project named ACTION-Grid. In this project the authors aimed to create a collaborative environment in biomedical and nanomedical research among countries in Europe, Western Balkans, Latin America, North Africa and the USA. METHODS We review and analyze the rationale and scientific issues behind the new fields of nanomedicine and nanoinformatics. Such a review is linked to actual research projects and achievements of the authors within their groups. RESULTS The work of the authors at the intersection between these two areas is presented. We also analyze several research initiatives that have recently emerged in the EU and USA context and highlight some ideas for future action at the international level. CONCLUSIONS Nanoinformatics aims to build new bridges between medicine, nanotechnology and informatics, allowing the application of computational methods in the nano-related areas. Opportunities for world-wide collaboration are already emerging and will be influential in advancing the field.

[1]  Masanori Sugisaka,et al.  From molecular biology to nanotechnology and nanomedicine. , 2002, Bio Systems.

[2]  王林,et al.  GoPubmed , 2010 .

[3]  R B Altman,et al.  Commentaries on “Informatics and Medicine: From Molecules to Populations” , 2008, Methods of Information in Medicine.

[4]  D Tomlinson,et al.  Liposomal doxorubicin (Doxil): an effective new treatment for Kaposi's sarcoma in AIDS. , 1994, Clinical oncology (Royal College of Radiologists (Great Britain)).

[5]  Victor Maojo,et al.  Nanoinformatics: New Challenges for Biomedical Informatics at the Nano Level , 2009, MIE.

[6]  Chris F. Taylor,et al.  A common open representation of mass spectrometry data and its application to proteomics research , 2004, Nature Biotechnology.

[7]  Martin Fritts,et al.  Nanoinformatics and DNA-Based Computing: Catalyzing Nanomedicine , 2010, Pediatric Research.

[8]  E. Zerhouni The NIH Roadmap , 2003, Science.

[9]  K. Leong,et al.  Controlled gene delivery by DNA-gelatin nanospheres. , 1998, Human gene therapy.

[10]  Robert A. Freitas,et al.  Nanomedicine, Volume I: Basic Capabilities , 1999 .

[11]  Viola Mr Potential of microparticles for diagnostic tracer imaging. , 1990 .

[12]  M. El-Samaligy,et al.  Reconstituted collagen nanoparticles, a novel drug carrier delivery system , 1983, The Journal of pharmacy and pharmacology.

[13]  Miguel García-Remesal,et al.  Building an Index of Nanomedical Resources: An Automatic Approach Based on Text Mining , 2008, KES.

[14]  Miguel García-Remesal,et al.  A Method for Indexing Biomedical Resources over the Internet , 2008, MIE.

[15]  F. Martín-Sánchez,et al.  Oligonucleotide microarray design for detection and serotyping of human respiratory adenoviruses by using a virtual amplicon retrieval software. , 2007, Journal of virological methods.

[16]  J. Kreuter Nanoparticles and nanocapsules--new dosage forms in the nanometer size range. , 1978, Pharmaceutica acta Helvetiae.

[17]  P. Cullis,et al.  Drug Delivery Systems: Entering the Mainstream , 2004, Science.

[18]  Jeffrey S. Morris,et al.  Feature extraction and quantification for mass spectrometry in biomedical applications using the mean spectrum , 2005, Bioinform..

[19]  Victor Maojo,et al.  Action GRID: assessing the impact of Nanotechnology on biomedical informatics. , 2008, AMIA ... Annual Symposium proceedings. AMIA Symposium.

[20]  C. Kulikowski The Micro-Macro Spectrum of Medical Informatics Challenges: From Molecular Medicine to Transforming Health Care in a Globalizing Society , 2002, Methods of Information in Medicine.

[21]  Kristen L. Helton,et al.  Microfluidic Overview of Global Health Issues Microfluidic Diagnostic Technologies for Global Public Health , 2006 .

[22]  Gordon Clapworthy,et al.  Digital Human Modelling: A Global Vision and a European Perspective , 2007, HCI.

[23]  A. Leson “There is plenty of room at the Bottom”. , 2005 .

[24]  Victor Maojo,et al.  European Efforts in Nanoinformatics Research Applied to Nanomedicine , 2009, MIE.

[25]  H. Mewes,et al.  Informatics and Medicine , 2008, Methods of Information in Medicine.

[26]  Victor Maojo,et al.  Reflections on Biomedical Informatics: From Cybernetics to Genomic Medicine and Nanomedicine , 2006, MIE.

[27]  S. Davis,et al.  Nanoparticles in drug delivery. , 1987, Critical reviews in therapeutic drug carrier systems.

[28]  K. Jain The Handbook of Nanomedicine , 2008, Humana Press.

[29]  V. Gewin Big opportunities in a small world. , 2009, Nature.

[30]  Robert A. Freitas,et al.  Nanomedicine, Volume Iia: Biocompatibility , 2003 .

[31]  M. Roco Nanotechnology: convergence with modern biology and medicine. , 2003, Current opinion in biotechnology.

[32]  B Blobel Architectural approach to eHealth for enabling paradigm changes in health. , 2010, Methods of information in medicine.

[33]  Bill C. White,et al.  Proteomic patterns of tumour subsets in non-small-cell lung cancer , 2003, The Lancet.

[34]  V Maojo,et al.  Medical Informatics and Bioinformatics: Integration or Evolution through Scientific Crises? , 2006, Methods of Information in Medicine.

[35]  G H López-Campos,et al.  Analysis and Management of HIV Peptide Microarray Experiments , 2006, Methods of Information in Medicine.

[36]  Joel H. Saltz,et al.  caGrid: design and implementation of the core architecture of the cancer biomedical informatics grid , 2006, Bioinform..

[37]  Nathan A. Baker,et al.  Ontologies for cancer nanotechnology research , 2009, 2009 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[38]  K. Nilsson Preparation of nanoparticles conjugated with enzyme and antibody and their use in heterogeneous enzyme immunoassays. , 1989, Journal of immunological methods.

[39]  Miguel García-Remesal,et al.  BIRI: a new approach for automatically discovering and indexing available public bioinformatics resources from the literature , 2009, BMC Bioinformatics.

[40]  Michihiro Nakamura,et al.  Nanomedicine for drug delivery and imaging: A promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles , 2007, International journal of cancer.

[41]  Kevin Robbie,et al.  Nanomaterials and nanoparticles: Sources and toxicity , 2007, Biointerphases.

[42]  Manolis Tsiknakis,et al.  An Integrated Clinico-Proteomics Information Management and Analysis Platform , 2008, 2008 21st IEEE International Symposium on Computer-Based Medical Systems.

[43]  M. Girolami,et al.  Clinical proteomics: A need to define the field and to begin to set adequate standards , 2007, Proteomics. Clinical applications.

[44]  S. Bonnet,et al.  Chromatographic alignment combined with chemometrics profile reconstruction approaches applied to LC-MS data , 2007, 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.